-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: BIOTECH
Bioscience Economic Development Needs Key Ingredients
Realizing that entrepreneurship is a key ingredient in economic development, states and localities continue to support programs that assist bioscience businesses and capitalize on the regional presence of universities and/or federal laboratories. With this fact in mind, Peter M. Pellerito, a senior policy consultant at BIO, and I recently collaborated on a report that investigates what specific steps have been taken across the United States as a means of attracting bioscience companies and expanding job Read More >
Venture Capital increases in 2011, but…
The National Venture Capital Association (NVCA) has released their 4Q 2011 numbers for biotech venture financing in the US. The report echoes the global numbers already out from BioCentury and BioWorld – a boost in investment for 2011. The take away, however, is not the total amount, but 1) the drop in the total number of biotech deals, and 2) the drop in start-up, early-stage deals from 2010. The total number of deals near 447 was down Read More >
Mass. Governor Patrick Looking Forward to the BIO International Convention
In just six months, Boston will be welcoming more than 15,500 of the world’s leading biotech stakeholders to the biggest industry event of the year – the 2012 BIO International Convention. Both Massachusetts Governor Deval Patrick and Boston Mayor Thomas Menino attended a kickoff breakfast in October where they voiced their industry support: “It’s an honor to have BIO coming back so soon,” said Gov. Patrick. “By drawing the world’s attention once again to our Read More >
Sizing up the NBI in 2011
How did the Nasdaq Biotechnology Index (NBI) perform in 2011 relative to other sectors? Second place. Not so bad considering 2011 was the year of defense in the stock market. Like a page out of a textbook on defensive market plays, utilities edged out ahead with a +15% gain, followed by consumer staples with 11%. The NBI squeezed in between at 12%, just above the overall healthcare sector. Overall, the S&P500 was flat for the Read More >
Georgia Bio Recognizes Two State Legislators with Annual Award
While the economic climate has been difficult for bioscience companies, it has also had a significant impact on state budgets, causing many states to cut programs and reassess economic priorities. That said, the bioscience industry has remained a valuable growth area, both in the United States and abroad. Therefore, it’s not surprising that local and state government leaders continue to support economic development initiatives that encourage the growth of this industry. This week, Georgia Bio Read More >
